{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:58:30Z","timestamp":1758707910213,"version":"3.40.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"vor","delay-in-days":948,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.7861\/clinmed.2021-0482","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T16:35:16Z","timestamp":1631291716000},"page":"e529-e530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy"],"prefix":"10.1016","volume":"21","author":[{"given":"Aisha","family":"Rummaan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Maryam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awais","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snigdhendu","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2021-0482_bib1","first-page":"579","article-title":"Management of amiodarone-induced thyrotoxicosis","volume":"133","author":"Rajeswaran","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"10.7861\/clinmed.2021-0482_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2265.2005.02249.x","article-title":"The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves\u2019 hyperthyroidism","volume":"62","author":"Tsai","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.7861\/clinmed.2021-0482_bib3","first-page":"3191","article-title":"Treatment of hyperthyroidism with a combination of methimazole and cholestyramine","volume":"81","author":"Mercado","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.7861\/clinmed.2021-0482_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1089\/thy.2008.0094","article-title":"Dramatic response to cholestyramine in a patient with Graves\u2019 disease resistant to conventional therapy","volume":"18","author":"Sebasti\u00e1n-Ochoa","year":"2008","journal-title":"Thyroid"},{"key":"10.7861\/clinmed.2021-0482_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.12659\/AJCR.893821","article-title":"Role of cholestyramine in refractory hyperthyroidism","volume":"16","author":"Alswat","year":"2015","journal-title":"Am J Case Rep"},{"key":"10.7861\/clinmed.2021-0482_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.7861\/clinmed.2021-0482_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3949\/ccjm.70.7.624","article-title":"Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies","volume":"70","author":"Cardenas","year":"2003","journal-title":"Cleve Clinic J Med"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147021182403077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147021182403077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2021-0482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:45:42Z","timestamp":1744447542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147021182403077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S147021182403077X"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2021-0482","relation":{},"ISSN":["1470-2118"],"issn-type":[{"type":"print","value":"1470-2118"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2021-0482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2021. All rights reserved.","name":"copyright","label":"Copyright"}]}}